Genetic Technologies Limited (ASX:GTG) Sells Affinity and EasyDNA Businesses
Genetic Technologies Limited (ASX:GTG) completes the sale of AffinityDNA and EasyDNA businesses to Endeavor DNA, Inc., streamlining operations amid administration.
Tag: Corporate Strategy & Guidance
European Lithium (ASX: EUR) Announces Maiden Drill Results
European Lithium (ASX: EUR) announces high-grade results from its Tanbreez Project drill program, indicating strong potential for rare-earth minerals.
European Lithium Limited (ASX:EUR) Responds to ASX Query
European Lithium Limited responds to an ASX query on its securities, confirming compliance and announcing drill results from the Tanbreez Project.
Belararox Limited (ASX: BRX) Commences Drilling at TMT Project
Belararox Limited commences drilling at the TMT Project, addressing promising copper and gold targets in Argentina.
Prospect Resources Ltd (ASX: PSC) Reports Strong Drilling Results
Prospect Resources Ltd (ASX: PSC) reports positive developments at its Mumbezhi Copper Project, with strong drill results and future plans for growth.
Viking Mines Limited (ASX:VKA) Defines High-Grade Gold Resource
Viking Mines (ASX:VKA) announces a new high-grade gold resource estimate at the First Hit Mine, enhancing its exploration potential.
Element 25 Limited (ASX:E25) Secures $166M Grant for Manganese Project
Element 25 Limited secures a US$166 million grant to support its high-purity manganese project in Louisiana, promising significant local economic benefits.
CLINUVEL PHARMACEUTICALS (ASX:CUV) Updates on CUV105 Case Reports
CLINUVEL Pharmaceuticals highlights positive findings in vitiligo treatment from the CUV105 study with SCENESSE® therapy.
MinRex Resources Limited (ASX: MRR) Announces Loyalty Option Offer
MinRex Resources (ASX: MRR) announces a Loyalty Option Offer to eligible shareholders, aiming to raise approximately $271,217.
Invex Therapeutics Ltd (ASX:IXC) Secures £114k R&D Tax Rebate
Invex Therapeutics secures £114k R&D tax rebate from UK government, aiding its focus on neurological drug development.